First, the selective inhibition of VEGFR-3 by EVT801 prevents tumor growth by impairing both tumor angiogenesis and lymphangiogenesis, which stabilizes tumor vasculature, decreases metastasis, and reduces hypoxia in the TME. The gene discussed is FLT4; the disease is neoplasm.